Discover AktiveX™, a clinically validated botanical innovation for Performance and vitality. Inspired by centuries-old ...

Artificial intelligence is increasingly influencing not just how consumers discover nutraceutical products, but what brands ...

A University of Florida study found an association between glucosamine supplementation and faster progression of Alzheimer’s ...

New research harnesses brain imaging to investigate how probiotic supplementation may have effects weeks after use stops.

Ashwagandha supplementation for 60 days has been shown to improve stress and anxiety, as well as triglyceride levels in individuals with mild stress, anxiety and hypertension.

Nestlé’s latest GLP-1 strategy suggests that what started as a supplement-industry opportunity is becoming a much broader nutrition category. GLP-1 drugs continue to gain traction, with 11% of U.S.

Find out more about trends happening in the GLP-1 nutrition category, eye health and kids’ supplement launches, as well as new market developments in Japan’s Foods with Function Claims (FFC) sector in ...

Australia’s Therapeutic Goods Administration (TGA) has released guidance on how NMN, NAD+, NAD and NADH can be represented in health supplements, with implications for naming, labeling and advertising ...

The winners of the 2026 NutraIngredients Awards came from every corner of the nutrition industry, but looking across this year’s categories, several common threads emerged... Healthy aging appeared ...

The U.S. Food and Drug Administration is proposing to make the currently voluntary GRAS notification system mandatory, giving the agency greater visibility into substances companies determine are ...

New Zealand dairy nutrition firm The a2 Milk Company’s recently released research results are set to drive growth in the US market and shape its innovation pipeline. The new study findings were ...

Hair growth supplements are one of the fastest growing categories in the beauty-from-within market, a trend increasingly linked to the rise of GLP-1 drugs. Since GLP-1 drugs went mainstream in the ...